| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R R Gainetdinov, A R Mohn, L M Bohn, M G Caro. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. vol 98. issue 20. 2001-12-04. PMID:11572967. |
the pharmacological effect of these drugs occurs without any observable changes in dopaminergic parameters, suggesting that other neurotransmitter systems in addition to dopamine might contribute to the control of locomotion in these mice. |
2001-12-04 |
2023-08-12 |
mouse |
| J D Troadec, M Marien, F Darios, A Hartmann, M Ruberg, F Colpaert, P P Miche. Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. Journal of neurochemistry. vol 79. issue 1. 2001-10-25. PMID:11595772. |
to better understand the neurotrophic function of the neurotransmitter noradrenaline, we have developed a model of mesencephalic cultures in which we find low concentrations (0.3-10 microm) of noradrenaline to be remarkably effective in promoting long-term survival and function of dopaminergic neurons. |
2001-10-25 |
2023-08-12 |
Not clear |
| M Boules, L Warrington, A Fauq, D McCormick, E Richelso. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. European journal of pharmacology. vol 426. issue 1-2. 2001-10-04. PMID:11525773. |
since dopaminergic neurotransmission underlies many of the behavioral properties of psychostimulants, and since neurotensin has been implicated in modulating dopaminergic neurotransmitter systems, we tested the effect of our novel neurotensin analog, nt69l (n-methyl-arg(8),l-lys(9),l-neo-trp(11),tert-leu(12)]neurotensin-(8-13)), on hyperactivity caused by cocaine and d-amphetamine. |
2001-10-04 |
2023-08-12 |
Not clear |
| J M Rho, T W Store. Molecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine. Journal of child neurology. vol 16. issue 4. 2001-09-06. PMID:11332462. |
in the past two decades, a wealth of information has emerged regarding the molecular biology and pharmacology of classic neurotransmitter receptors (including adrenergic, dopaminergic, serotonergic, cholinergic, glycine, gamma-aminobutyric acid [gaba(a)], and glutamate receptors). |
2001-09-06 |
2023-08-12 |
Not clear |
| B H King, D M Wright, M Snape, C T Douris. Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry. vol 40. issue 6. 2001-07-26. PMID:11392342. |
a growing body of literature implicates interactions between glutamatergic and neostriatal dopaminergic neurotransmitter systems in the development and expression of impulsivity, hyperactivity, and stereotypy. |
2001-07-26 |
2023-08-12 |
Not clear |
| L C Salan. The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain research bulletin. vol 54. issue 6. 2001-07-26. PMID:11403984. |
it also provides a discussion of stimulatory molecules which are likely to affect peptide release, particularly the neurotransmitter serotonin, which may be present via uptake into the dopaminergic nerve terminals. |
2001-07-26 |
2023-08-12 |
Not clear |
| L Lykouras, M Markianos, J Hatzimanolis, P Oulis, G Christodoulo. Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 8. 2001-07-12. PMID:11175925. |
certain studies on measures related to central neurotransmitter activity have demonstrated that in delusional (psychotic) depression there is a dopaminergic dysregulation which distinguishes it from non-psychotic depression. |
2001-07-12 |
2023-08-12 |
Not clear |
| S J Kish, K S Kalasinsky, P Derkach, G A Schmunk, M Guttman, L Ang, V Adams, Y Furukawa, J W Haycoc. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 24. issue 5. 2001-07-12. PMID:11282256. |
to establish whether chronic opiate exposure might impair brain dopaminergic or serotonergic function in humans, we assessed biochemical indices of monoaminergic neurotransmitter activity and integrity in post mortem striatum of nine chronic heroin users and 14 control subjects. |
2001-07-12 |
2023-08-12 |
human |
| A Ishisaki, H Hayashi, S Suzuki, K Ozawa, E Mizukoshi, K Miyakawa, M Suzuki, T Imamur. Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells. Journal of neurochemistry. vol 77. issue 5. 2001-07-12. PMID:11389187. |
the finding that the neurotransmitter dopamine induces apoptosis in neurons implies the existence of a cellular mechanism by which dopaminergic neurons protect themselves from dopamine-induced apoptosis. |
2001-07-12 |
2023-08-12 |
Not clear |
| D Li, P Chokka, P Tibb. Toward an integrative understanding of social phobia. Journal of psychiatry & neuroscience : JPN. vol 26. issue 3. 2001-07-05. PMID:11394189. |
evidence of specific dysfunction of dopaminergic, serotonergic, noradrenergic and gabaergic (gamma-aminobutyric acid) neurotransmitter systems has been presented in animal models, challenge studies and treatment investigations. |
2001-07-05 |
2023-08-12 |
Not clear |
| J Peusken. Switching approach in the management of schizophrenia patients. International clinical psychopharmacology. vol 15 Suppl 4. 2001-06-07. PMID:11252519. |
furthermore, the highly selective affinity of amisulpride for dopaminergic receptors with its lack of interference with other neurotransmitter systems facilitates the change in treatment. |
2001-06-07 |
2023-08-12 |
Not clear |
| M Yamada, A Natsume, M Mata, T Oligino, J Goss, J Glorioso, D J Fin. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Experimental neurology. vol 168. issue 2. 2001-05-10. PMID:11259110. |
we have previously demonstrated that a genomic herpes simplex virus (hsv)-based vector expressing the anti-apoptotic peptide bcl-2 protects dopaminergic neurons of the substantia nigra from neurotoxin-induced apoptotic cell death and preserves the neurotransmitter phenotype of those cells. |
2001-05-10 |
2023-08-12 |
rat |
| A Ajamieh, M Anssea. [Biological markers in schizotypal and borderline personality disorders]. L'Encephale. vol 26. issue 6. 2001-04-05. PMID:11217538. |
in the field of neurobiochemistry, the dopaminergic and serotonergic systems seem to be implicated in the etiology of spd while several data point out the fact that several neurotransmitter systems (dopaminergic, serotonergic, noradrenergic and cholinergic) seem to be involved in the etiology of bpd. |
2001-04-05 |
2023-08-12 |
Not clear |
| S Dresel, J Krause, K H Krause, C LaFougere, K Brinkbäumer, H F Kung, K Hahn, K Tatsc. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. European journal of nuclear medicine. vol 27. issue 10. 2001-03-01. PMID:11083541. |
the data of this study help to elucidate the complex dysregulation of the dopaminergic neurotransmitter system in patients suffering from adhd and the effect of treatment with psychoactive drugs. |
2001-03-01 |
2023-08-12 |
human |
| J F Quist, C L Barr, R Schachar, W Roberts, M Malone, R Tannock, V S Basile, J Beitchman, J L Kenned. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Molecular psychiatry. vol 5. issue 5. 2001-02-01. PMID:11032388. |
the complex interaction between the serotonergic and dopaminergic neurotransmitter systems suggests that a balance between the two systems may be necessary for mediating hyperactive behaviour. |
2001-02-01 |
2023-08-12 |
mouse |
| M Kapsimali, H Dumond, S Le Crom, S Coudouel, J D Vincent, P Vernie. [Evolution and development of dopaminergic neurotransmitter systems in vertebrates]. Journal de la Societe de biologie. vol 194. issue 2. 2001-01-18. PMID:11098433. |
[evolution and development of dopaminergic neurotransmitter systems in vertebrates]. |
2001-01-18 |
2023-08-12 |
Not clear |
| S L Minger, M M Esiri, B McDonald, J Keene, J Carter, T Hope, P T Franci. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology. vol 55. issue 10. 2001-01-04. PMID:11094098. |
this study investigated the relationship between markers of the cholinergic and dopaminergic neurotransmitter systems and noncognitive behavioral symptoms assessed during the course of dementing illness. |
2001-01-04 |
2023-08-12 |
Not clear |
| J Kulisevsk. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & aging. vol 16. issue 5. 2000-11-13. PMID:10917074. |
enhancement and impairment of cognitive function with dopaminergic treatment is incomplete and task-specific, suggesting the need to integrate the above dopamine facts with other neurotransmitter systems findings in pd. |
2000-11-13 |
2023-08-12 |
human |
| N S Lamango, C G Charlto. Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. Pharmacology, biochemistry, and behavior. vol 66. issue 4. 2000-11-07. PMID:10973524. |
these data indicate that intracerebroventricular injection of sam may induce pd symptoms by interfering with the methylation/demethylation homeostasis of prenylated proteins that function in the dopaminergic and other signaling pathways, and that the fc analogs may counteract the sam effects by acting synergistically on events subsequent to neurotransmitter release. |
2000-11-07 |
2023-08-12 |
rat |
| M Martin-Negrier, G Charron, B Bloc. Agonist stimulation provokes dendritic and axonal dopamine D(1) receptor redistribution in primary cultures of striatal neurons. Neuroscience. vol 99. issue 2. 2000-10-19. PMID:10938431. |
to investigate the influence of neurotransmitter on g-protein-coupled receptor trafficking and compartimentalization in neurons, we have developed a model of primary neuronal cultures from fetal rat striatum on which we have studied the cellular and subcellular distribution and trafficking of the d(1) dopaminergic receptor. |
2000-10-19 |
2023-08-12 |
rat |